An interventional study of Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine in Pain, Shoulder, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 21 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-16.
Sponsored by Zagazig University · Not applicable, Interventional, and Supportive care
The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes:
Control Group (C Group) : Patients receive continuous US suprascapular nerve block only.
Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.
Both groups compared as regard:
Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium
411 studies on the registry are indexed under Bursitis; 112 are open to participants now.
This study's enrollment of 40 is below the median of 45 across 371 interventional studies indexed under Bursitis.
Browse Bursitis studies →Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients will receive continuous US suprascapular nerve block only.
Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine
Patients will receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.
Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine
The high frequency linear ultrasound transducer (Sonosite 6-13 MHz) in a transverse orientation will be placed over the scapular Spine. Moving the transducer cephalad the suprascapular fossa will be identified. 18 gauge touhy needle will be inserted in plane after subcutaneous local anesthesia infiltration with 1 ml lidocaine 2% Real-time imaging will be used to direct injection of 2 ml lidocaine 2% to test perineural spread of injectate after confirmation of the position of tip of needle injection of 40mg methyl prednisolone diluted in 5 ml bupivacaine 0.5% will be done through the needle to anesthetize the nerve and create space for catheter insertion. After catheter insertion another 2 ml lidocaine 2% will be injected through the catheter to confirm position perineural in the scapular notch. Lastly Catheter will be fixed via skin tunnel and secured with skin sutures and adhesive tap.
Also known as: Oral gabapentin 300 mg at bed time in GG
Visual analogue scale
10cm line where zero means no pain and ten means worse imaginary pain
Time frame: 6 weeks
Range of passive and active movements
by goniometer
Time frame: 6 weeks
Patients satisfaction
by questionnaire with 3 degrees 1. Fair 2. Good 3. Excellent
Time frame: 6 weeks
The total dose of diclofenac sodium
Indicator for analgesia required
Time frame: 6 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zagazig University